Randall A. Ow, MD, FACS, FARS, FAAOA, FAPCR

I enjoy the privilege of helping a patient understand their problem and treat the condition with medicine or surgery, and see the joy in the patient after helping them heal from disease. I love seeing patients of all ages in my practice and am truly challenged by the broad practice of otolaryngology. I have a special interest in research, which serves to advance medicine in all areas, and I have helped to bring to market new therapies and medical devices that continue to provide better ways to combat disease and illness.

Specialties: 

Clinical research, sinus, thyroid, sleep surgery, pediatrics, office-based therapies

Undergraduate Degree: 

Bachelor of Arts, University of Hawaii at Manoa in 1983

Medical Degree(s): 

Uniformed Services University of Health Sciences, Bethesda, Maryland 1989

Internship/Externship: 

General Surgery Internship David Grant USAF Medical Center, Travis AFB, CA in 1990

Residency: 

Wilford Hall USAF Medical Center, Otolaryngology-Head & Neck Surgery Residency in 1998, San Antonio, Texas

Certifications & Affiliations:

• Fellow of the American College of Surgeons
• Fellow of the American Rhinologic Society
• Fellow of the American Academy of Otolaryngic Allergy
• Fellow of the Academy of Physicians in Clinical Research

Publications:

• Ow, RA, et.al., Steroid-eluting sinus implant for in-office treatment of recurrent polyposis: A pharmacokinetic study. Int Forum Allergy Rhinology, 9/30/14.
• Smith, T, Ow, RA, et. al.,Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening. Laryngoscope, 12/1/2016.
• Han, J., Ow, RA, et al, RESOLVE: A randomized, controlled, blinded study of bioabsorbable steroid eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinology, 11/1/2014.
• Luong, A, Ow, RA, et al., SAFETY AND EFFECTIVENESS OF A BIORESORBABLE STEROID-RELEASING IMPLANT FOR THE PARANASAL SINUS OSTIA: A RANDOMIZED CLINICAL TRIAL. JAMA – otolaryngology-head & neck surgery. 2017 Nov 4.
• Stolovitsky, P., Ow, RA, et al., A PROSPECTIVE STUDY FOR TREATMENT OF NASAL VALVE COLLAPSE DUE TO LATERAL WALL INSUFFICIENCY: OUTCOMES USING A BIORESORBABLE IMPLANT. Laryngoscope,128:2483-2489, 2018 May 15.
• Singh, A., Ow, RA, et al., BIOABSORBABLE STEROID-RELEASING IMPLANTS IN THE FRONTAL SINUS OSTIA: A POOLED ANALYSIS. Int Forum Allergy Rhinol, 9: 131-139, 2019 Nov 16.
• Bachert, C, Ow, R.A., et al., BASELINE CHARACTERISTICS OF PHASE 3 RANDOMIZED CONTROLLED TRIALS OF OMALIZUMAB IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. Allergy. 2019 Jan 14.
• Yen, D, Ow, R.A., et al., IN-OFFICE TYMPANOSTOMY TUBE PLACEMENT USING AN IONTOHORESIS AND TUBE DELIVERY SYSTEM. OTO Open Feb 2020, 4(1) 1-7.
• Stolovitsky, P., Ow, RA, et al., IN-OFFICE PLACEMENT OF MOMETASONE FUROATE SINUS IMPLANTS FOR RECURRENT NASAL POLYPS: A POOLED ANALYSIS. Am J Rhinology Allergy. 2019 May 24.
• Stolovitsky, P., Ow, RA, et al., ASSESSMENT OF BIOABSORBABLE IMPLANT TREATMENT FOR NASAL VALVE COLLAPSE COMPARED TO A SHAM GROUP: A RANDOMIZED CONTROLLED TRIAL. Int Forum Allergy Rhinol 2019: 9: 850-856, 2019 Jun 22.
• Gevaert P, Bachert C, Corren J, Mullol J, Han J, Ow R, Islam L, Howard M, Owen R, Wong K, Kaufman D, Omachi T. Omalizumab efficacy and safety in nasal polyposis: Results from two parallel, double-blind, placebo-controlled trials. Ann Allergy Asthma Immunol. 2019;123(5):S17.
• Lustig, L.R., Ow, R.A., et al., IN-OFFICE TYMPANOSTOMY TUBE PLACEMENT IN CHILDREN USING IONOTOPORESIS AND AUTOMATED TUBE DELIVERY SYSTEM. Laryngoscope, 130:S1-S9, 2020 Mar 12.
• Sidle, D.M., Ow, R.A., et al., TWELVE-MONTH OUTCOMES OF A BIORESORBABLE IMPLANT FOR IN-OFFICE TREATMENT OF DYNAMIC NASAL VALVE COLLAPSE. Laryngoscope, 130:1132-1137, 2020 May 1.
• Svider, P, Ow, RA, et al., INCORPORATION OF TELEMEDICINE BY RHINOLOGISTS: THE COVID-19 PANDEMIC AND BEYOND. Amer Journal Oto 2020 May 27.
• Wu, A.W., Ow, R.A., et al., EFFECT OF NASAL FLUTICASONE EXHALATION DELIVERY SYSTEM ON EUSTACHIAN TUBE DYSFUNCTION. Int Forum Allergy Rhinology 2020 Nov 3.
• Sidle, D, Ow, R.A., et al., TWO-YEAR OUTCOMES OF A BIOABSORBABLE IMPLANT FOR TREATMENT OF DYNAMIC NASAL VALVE COLLAPSE. Journal 2020 Dec 1.
• Ow, R.A., O’Malley EM, Han, JK, Lam, KK, AND Yen, DM. CRYOSURGICAL ABLATION FOR TREATMENT OF RHINITIS: 2-YEAR RESULTS OF A PROSPECTIVE MULTICENTER STUDY. Laryngoscope. 131:1952-1957. 2021.
• Nachlas, N, Ow, RA, et al., BIOABSORBALE IMPLANT FOR TREATMENT OF NASAL
  VALVE COLLAPSE WITH OR WITHOUT CONCOMITANT PROCEDURES.
  Facial Plas Surg. 2021 Feb.
• Yao, W, Ow, R.A., et al., TEMPERATURE-CONTROLLED RADIOFREQUENCY TREATMENT OF THE NASAL VALVE AND NASAL AIRWAY OBSTRUCTION: EARLY RESULTS OF A PROSPECTIVE, MULTI-CENTER STUDY. Journal. 2021 Jul 10.
• Stolovitzky, J, Ow, R.A., et al., EFFECT OF RADIOFREQUENCY NEUROLYSIS ON THE SYMPTOMS OF CHRONIC RHINISTIS: A RANDOMIZED CONTROLLED TRIAL. OTO OPEN 2021, VOL. 5(3) 1-7. 2021 Aug 3.
• Bikhazi, N, Ow, R.A., et al., LONG-TERM FOLLOW-UP FROM THE TREATMENT AND CROSSOVER ARMS OF A RANDOMIZED CONTROLLED TRIAL OF AN ABSORBABLE NASAL IMPLANT FOR DYNAMIC NASAL VALVE COLLAPSE. Facial Plastic Surgery. 2021, 10.1055/s0041-1740948.
• Gavaert, P, Ow, R.A., et al., LONG-TERM EFFICACY AND SAFETY OF OMALIZUMAB FOR NASAL POLYPOSIS IN AN OPEN-LABEL EXTENSION STUDY. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 149 (1), 2021 JULY 13.
• Ow, R.A., et al., THE EFFECT OF EDS-FLU ON OBJECTIVE AND PATIENT-REPORTED SUBJECTIVE OUTCOMES FOR PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. Ear, Nose and Throat Journal. 2022 Mar 3.
• Ow, R.A., et al., PHARMACOKINETIC EVIDENCE OF CONSISTENT AND SUSTAINED DRUG RELEASE FROM LONG-ACTING IMPLANTABLE CORTICOSTEROID MATRICES FOR CHRONIC RHINOSINUSITIS. American Journal of Rhinology and Allergy. (x):1-8. Jun 2022.
• Takashima, M, Ow, R.A., et al., TEMPERATURE-CONTROLLED RADIOFREQUENCY NEUROLYSIS FOR TREATMENT OF CHRONIC RHINITIS: 12-MONTH OURCOMES AFTER TREATMENT IN A RANDOMIZED CONTROLLED TRIAL. Int Forum Allergy Rhinology. 2022 June 17.
• Ow, R.A. Soler, ZM, Sindwani, R, Leopold, DA, Lee, JT, Mahmoud, RA, and Han, JK. EFFICACY OF THE EXHALATION DELIVERY SYTEMWITH FLUTICASONE (EDS-FLU) IN PATIENTS WITH CHROIC RHINOSINUSITIS WITH POLYPS WHOSE SYMPTOMS RECUR AFTER SINUS SURGERY. Int Forum Allergy Rhinology. 2022 June 17.
• Sidle, DM, Ow, RA, et al., BIOABSORBABLE IMPLANT FOR TREATMENT OF NASALVALVE COLLAPSE WITH OR WITOUT CONCOMITANT PROCEDURES. Facial Plastic Surgery, 37(07), 2021 Apr 14.
• Han, JK, Ow, RA, et al., MEPOZLIZUMAB FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (SYNAPSE): A RANDOMISED, PLACEBO-CONTORLLED, PHASE 3 TRIAL. Lancet Resp Medicine, 9 (suppl S 29), April 2021.
• Corren, J, Bachert, C., Gevaert, P, Ow, RA, et al., OMALIZUMAB IMPROVES QUALITY OF LIFE IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AND COMORBID ASTHMA. Journal of Allergy and Clinical Immunology. 145(2): AAB250, Feb 2020.
• Bachert, C, Gevaert, P, Corren, J, Mullol, J, Han, J, Ow, RA, et, al., OMALIZUMAB IMPORVES OUTCOMES IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS IRRESPECTIVE OF ASTHMA STATUS. Journal of Allergy and Clinical Immunology. 145(2): AAB149, Feb 2020.
• Gavaert, P, Bachert, C, Corren, J, Mullol, J, Han, J, Ow, RA, et, al., OMALIZUMAB EFFICACY AND SAFETY IN NASAL POLYPOSIS: RESULTS FROM TWO PARALLE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS. Annals of Allergy, Asthma and Immunology, 123(5)S17, Nov. 2019.

Community/Organization Involvement:

• Executive Board Member, St. Albans Country Day School, President DaVinci Research
• Volunteer Clinical Faculty, UCD School of Medicine
• Clinical Faculty, UCD School of Nursing
• Preceptor, California Northstate School of Medicine
• Development Committee, International Surgical Sleep Society
• Clinical Faculty, Sutter Roseville General Surgery Residency

Hobbies/Activities:

Coaching track and field, basketball, fitness, golf, travel

Locations

• Roseville (Medical Plaza Dr)